TABLE 7

Alterations in the discriminative-stimulus potency of cocaine produced by treatment with N-substituted BZT analogs ED50 values and potencies relative to cocaine alone (with 95% CL) are shown.


Drug

ED50 (μmol/kg)

Relative Potencya
Cocaine 9.68 (6.62-13.9) 1.0
0.18 WIN 35,428 + cocaine 5.83b (3.30-22.9) 1.24 (0.643-2.09)
1.77 WIN 35,428 + cocaine Nonsignificant linear regression 574 c (260-1810)
0.76 AHN 1-055 and cocaine 14.1 (8.15-37.6) 0.657 (0.353-1.14)
2.54 AHN 1-055 and cocaine 9.85 (4.85-22.0) 0.903 (0.491-1.63)
3.6 AHN 1-055 and cocaine 9.65 (6.39-13.7) 1.13 (0.750-1.75)
14.2 AHN 1-055 and cocaine Nonsignificant linear regression 1.94 (1.03-4.30)
2.73 AHN 2-003 + cocaine 8.32 (4.88-14.2) 1.06 (0.601-1.87)
8.20 AHN 2-003 + cocaine 6.97 (4.21-10.5) 1.26 (0.776-2.10)
15.3 AHN 2-003 + cocaine Nonsignificant linear regression 0.919 (0.508-1.68)
2.37 JHW 007 + cocaine 13.4 (9.32-21.7) 0.682 (0.382-1.15)
7.11 JHW 007 + cocaine 10.1 (6.62-15.7) 0.880 (0.518-1.48)
23.7 JHW 007 + cocaine Nonsignificant linear regression 1.66c (0.766-4.20)
13.8 AHN 2-005 + cocaine 6.94b (5.35-8.68) 1.29 (0.849-2.00)
24.6 AHN 2-005 + cocaine Nonsignificant linear regression 1.12c (0.490-2.69)
5.60 JHW 005 + cocaine 6.53 (3.38-10.3) 1.33 (0.800-2.31)
10.5 JHW 005 + cocaine 7.00 (3.00-12.5) 1.21 (0.696-2.19)
18.7 JHW 005 + cocaine
Nonsignificant linear regression
2.15 c , d (1.04-5.77)
  • a Significant relative potency values are indicated by italics

  • b Value is an estimate due to a significant deviation from linearity

  • c Value is an estimate due to a significant deviation from parallel

  • d Value is an estimate due to a significant effect of preparations